Sign in to your account
or
By signing in you agree to our
Terms & conditions
 and 
Privacy policy

Docaravimab + Miromavimab

Written By Dr. Sakshi JainReviewed By Dr. Rajeev Sharma
Last updated 31 May 2024 | 05:46 AM (UTC)

Docaravimab + Miromavimab Uses

Docaravimab+Miromavimab is used in the treatment of Rabies.

How Docaravimab + Miromavimab works

Rabies is a viral infection caused by the rabies virus which primarily affects the nervous system. Once the virus enters the body through a bite from an infected animal, it travels along nerve fibers to the central nervous system, including the brain. There, it can cause severe neurological symptoms and, ultimately, death if left untreated. Docaravimab + Miromavimab contains two antibodies: docaravimab and miromavimab. These antibodies bind to the rabies virus and prevent it from entering and infecting nerve cells and other cells in the body. This interruption of the virus's ability to replicate and spread within the body is crucial for halting the progression of rabies infection.

Common side effects of Docaravimab + Miromavimab

Injection site reactions (pain, swelling, redness)
Authenticity

Want to Know More

Read Our Editorial Policy

Medicine brands for Docaravimab + Miromavimab

Expert advice for Docaravimab + Miromavimab

  • All cases of rabies exposure should be treated immediately for the prevention of clinical symptoms and death.
  • Docaravimab + Miromavimab is prescribed for post-exposure risk prevention after contact with an infected animal or an animal suspected to have rabies infection.
  • No skin sensitivity test is required.
  • Docaravimab + Miromavimab should be given by a trained healthcare professional.
  • Follow the recommended dosing schedule.